Demand for Pfizer’s COVID pills lags
London – Worldwide demand for the oral COVID-19 anti-viral treatment, Paxlovid manufactured by Pfizer has been unexpectedly light due to complicated eligibility requirements, reduced testing,...
Copyright © 1997 - 2025, Nation Publishing Co. Limited • P.O. Box 1203, Fontabelle, St. Michael, BB11000, Barbados, West Indies • All Rights Reserved No unauthorized use is permitted of content produced by NationNews.com, The Nation Newspaper or any other publication or media owned by Nation Publishing Co. Limited. Unauthorized use includes framing and direct posting of content on websites other than www.nationnews.com.